A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor.

PubWeight™: 2.93‹?› | Rank: Top 1%

🔗 View Article (PMC 556542)

Published in EMBO J on March 01, 1992

Authors

A Baniahmad1, A C Köhne, R Renkawitz

Author Affiliations

1: Max-Planck-Institut für Biochemie, Genzentrum, Martinsried, FRG.

Articles citing this

Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc Natl Acad Sci U S A (1996) 3.61

Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc Natl Acad Sci U S A (1993) 3.09

The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol (1996) 2.87

CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab-8 insulator. EMBO Rep (2005) 2.80

Functional domains of the Drosophila Engrailed protein. EMBO J (1993) 2.73

Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J (1994) 2.62

A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains. Mol Cell Biol (1996) 2.47

CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proc Natl Acad Sci U S A (1996) 2.41

The tau 4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol Cell Biol (1995) 2.39

Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37

Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes Dev (1998) 2.24

A regulatory system for use in gene transfer. Proc Natl Acad Sci U S A (1994) 2.22

SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers. Proc Natl Acad Sci U S A (1996) 2.04

Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol (1997) 1.87

Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc Natl Acad Sci U S A (1993) 1.81

The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol Cell Biol (1995) 1.76

The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol (1999) 1.70

SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc Natl Acad Sci U S A (1999) 1.63

The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol (1998) 1.61

Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol (1997) 1.60

The transcriptional repressor even-skipped interacts directly with TATA-binding protein. Mol Cell Biol (1995) 1.59

Unliganded thyroid hormone receptor alpha can target TATA-binding protein for transcriptional repression. Mol Cell Biol (1996) 1.57

Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol Cell Biol (1994) 1.57

ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J (1995) 1.56

Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. EMBO J (1998) 1.52

A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor). Mol Cell Biol (1993) 1.52

Transcriptional repression by the SMRT-mSin3 corepressor: multiple interactions, multiple mechanisms, and a potential role for TFIIB. Mol Cell Biol (1998) 1.51

Steroid receptor induction of gene transcription: a two-step model. Proc Natl Acad Sci U S A (1997) 1.50

Determinants of chromatin disruption and transcriptional regulation instigated by the thyroid hormone receptor: hormone-regulated chromatin disruption is not sufficient for transcriptional activation. EMBO J (1997) 1.45

Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol (1999) 1.42

Cloning and characterization of a corepressor and potential component of the nuclear hormone receptor repression complex. Proc Natl Acad Sci U S A (1997) 1.41

Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses. Proc Natl Acad Sci U S A (1992) 1.41

Mapping and mutagenesis of the amino-terminal transcriptional repression domain of the Drosophila Krüppel protein. Mol Cell Biol (1994) 1.40

Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol Cell Biol (1994) 1.37

A novel role for helix 12 of retinoid X receptor in regulating repression. Mol Cell Biol (1999) 1.36

Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol Cell Biol (1996) 1.32

The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol Cell Biol (1993) 1.31

Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain. Nucleic Acids Res (1994) 1.28

Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res (1996) 1.28

Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol Cell Biol (1995) 1.28

Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol Cell Biol (2003) 1.27

Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression. Mol Cell Biol (1997) 1.26

Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression. Mol Cell Biol (1996) 1.23

Multiple steps in the regulation of transcription-factor level and activity. Biochem J (1996) 1.23

A domain of the even-skipped protein represses transcription by preventing TFIID binding to a promoter: repression by cooperative blocking. Mol Cell Biol (1995) 1.19

Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6. Mol Cell Biol (1998) 1.17

Both thyroid hormone and 9-cis retinoic acid receptors are required to efficiently mediate the effects of thyroid hormone on embryonic development and specific gene regulation in Xenopus laevis. Mol Cell Biol (1997) 1.17

Transcriptional silencing is defined by isoform- and heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol (1998) 1.16

Distinct binding determinants for 9-cis retinoic acid are located within AF-2 of retinoic acid receptor alpha. Mol Cell Biol (1994) 1.11

Negative regulation of transcription in eukaryotes. Biochem J (1993) 1.10

The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation. Mol Cell Biol (1995) 1.10

Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha. Proc Natl Acad Sci U S A (1993) 1.08

Core promoter elements and TAFs contribute to the diversity of transcriptional activation in vertebrates. Mol Cell Biol (2003) 1.07

The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc Natl Acad Sci U S A (1996) 1.07

The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol Cell Biol (1993) 1.04

Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity. Mol Cell Biol (1997) 1.03

Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression. Mol Cell Biol (1997) 1.03

A conformational switch in nuclear hormone receptors is involved in coupling hormone binding to corepressor release. Mol Cell Biol (1997) 1.02

Transcriptional anti-repression. Thyroid hormone receptor beta-2 recruits SMRT corepressor but interferes with subsequent assembly of a functional corepressor complex. J Biol Chem (1999) 1.02

Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc Natl Acad Sci U S A (1992) 1.02

Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter. Nucleic Acids Res (2002) 1.00

Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Mol Endocrinol (2005) 1.00

Transcriptional activation by the orphan nuclear receptor ARP-1. Nucleic Acids Res (1995) 0.98

Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. EMBO J (1998) 0.97

COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res (1995) 0.96

The mechanism by which the human apolipoprotein B gene reducer operates involves blocking of transcriptional activation by hepatocyte nuclear factor 3. Mol Cell Biol (1993) 0.96

Domain structure of the NRIF3 family of coregulators suggests potential dual roles in transcriptional regulation. Mol Cell Biol (2001) 0.95

Direct modulation of simian virus 40 late gene expression by thyroid hormone and its receptor. J Virol (1997) 0.94

The dual effect of adenovirus type 5 E1A 13S protein on NF-kappaB activation is antagonized by E1B 19K. Mol Cell Biol (1996) 0.94

Thyroid hormone receptor orthologues from invertebrate species with emphasis on Schistosoma mansoni. BMC Evol Biol (2007) 0.93

Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1. Nucleic Acids Res (1996) 0.92

Evidence for impaired retinoic acid receptor-thyroid hormone receptor AF-2 cofactor activity in human lung cancer. Mol Cell Biol (1995) 0.89

Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. Nucleic Acids Res (1996) 0.88

Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras. Mol Cell Biol (2005) 0.88

Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor. Mol Cell Biol (1996) 0.87

A shift in the ligand responsiveness of thyroid hormone receptor alpha induced by heterodimerization with retinoid X receptor alpha. Mol Cell Biol (1996) 0.86

Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Mol Cell Biol (1997) 0.83

A highly selective, label-free, homogenous luminescent switch-on probe for the detection of nanomolar transcription factor NF-kappaB. Nucleic Acids Res (2011) 0.83

Multiple receptor interaction domains of GRIP1 function in synergy. Nucleic Acids Res (1998) 0.83

Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation. Am J Clin Exp Urol (2014) 0.82

Two silencing sub-domains of v-erbA synergize with each other, but not with RXR. Nucleic Acids Res (1994) 0.81

New retinoid X receptor subtypes in zebra fish (Danio rerio) differentially modulate transcription and do not bind 9-cis retinoic acid. Mol Cell Biol (1995) 0.80

Thyroid hormone and leptin in the testis. Front Endocrinol (Lausanne) (2014) 0.79

A novel cytoplasmic adaptor for retinoic acid receptor (RAR) and thyroid receptor functions as a Derepressor of RAR in the absence of retinoic acid. J Biol Chem (2010) 0.79

tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors. Mol Cell Biol (1997) 0.79

Multiple mutations contribute to repression by the v-Erb A oncoprotein. Oncogene (2005) 0.78

Specific mutations in the ligand binding domain selectively abolish the silencing function of human thyroid hormone receptor beta. Proc Natl Acad Sci U S A (1995) 0.78

Characterization of downstream elements in a Raf-1 pathway. Proc Natl Acad Sci U S A (1993) 0.78

Retinoid isomers differ in the ability to induce release of SMRT corepressor from retinoic acid receptor-alpha. J Biol Chem (1999) 0.77

Articles cited by this

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75

The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68

How eukaryotic transcriptional activators work. Nature (1988) 19.34

Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: identification of a class of bipartite nuclear targeting sequence. Cell (1991) 9.96

Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell (1991) 8.85

New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63

Identification of a receptor for the morphogen retinoic acid. Nature (1988) 8.32

The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature (1987) 7.06

Nuclear receptors enhance our understanding of transcription regulation. Trends Genet (1988) 5.95

Transcriptional repression of eukaryotic promoters. Cell (1989) 5.60

A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature (1990) 4.57

Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature (1989) 4.47

The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell (1991) 4.27

Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell (1990) 4.13

Developmental regulation of beta-globin gene switching. Cell (1988) 4.11

The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell (1988) 3.91

An amino-terminal fragment of GAL4 binds DNA as a dimer. J Mol Biol (1989) 3.65

Retinoic acid and thyroid hormone induce gene expression through a common responsive element. Nature (1988) 3.42

Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37

Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer. Cell (1989) 3.24

Drosophila Krüppel protein is a transcriptional repressor. Nature (1990) 3.24

Identification of a novel thyroid hormone receptor expressed in the mammalian central nervous system. Science (1987) 3.13

Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology (1979) 3.04

Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature (1989) 2.78

Transcriptional repression in eukaryotes. Trends Genet (1990) 2.65

Active repression of transcription by the engrailed homeodomain protein. EMBO J (1991) 2.50

v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell (1990) 2.31

Dual regulatory role for thyroid-hormone receptors allows control of retinoic-acid receptor activity. Nature (1989) 2.23

A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. Mol Endocrinol (1989) 2.16

Role of the v-erbA and v-erbB oncogenes of avian erythroblastosis virus in erythroid cell transformation. Cell (1983) 2.08

Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J (1987) 2.07

A functional interaction between the C-terminal domain of RNA polymerase II and the negative regulator SIN1. Cell (1991) 2.05

Regulation of progesterone receptor-mediated transcription by phosphorylation. Science (1990) 1.82

Mutations that alter both localization and production of a yeast nuclear protein. Genes Dev (1988) 1.78

Multiple cell type-specific proteins differentially regulate target sequence recognition by the alpha retinoic acid receptor. Cell (1990) 1.75

v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene. Cell (1988) 1.55

A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes. EMBO J (1987) 1.54

Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. New Biol (1989) 1.45

Characterization of the hormone-binding domain of the chicken c-erbA/thyroid hormone receptor protein. EMBO J (1988) 1.26

c-erbA encodes multiple proteins in chicken erythroid cells. Mol Cell Biol (1988) 1.16

Ligand-activated thyroid hormone and retinoic acid receptors inhibit growth factor receptor promoter expression. Cell (1990) 1.16

Proliferation and differentiation of embryonic chick sympathetic neurons: effects of ciliary neurotrophic factor. Neuron (1989) 1.14

Ecdysterone regulatory elements function as both transcriptional activators and repressors. Mol Cell Biol (1991) 1.11

Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression. Oncogene (1990) 0.94

Genetic dissection of functional domains within the avian erythroblastosis virus v-erbA oncogene. Mol Cell Biol (1988) 0.89

Articles by these authors

Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res (1999) 12.83

CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet (2001) 6.80

Modular structure of a chicken lysozyme silencer: involvement of an unusual thyroid hormone receptor binding site. Cell (1990) 4.13

Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature (1988) 3.69

Many transcription factors interact synergistically with steroid receptors. Science (1988) 3.49

Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters. Nature (1985) 3.45

Sequences in the promoter region of the chicken lysozyme gene required for steroid regulation and receptor binding. Cell (1984) 3.01

Mouse lysozyme M gene: isolation, characterization, and expression studies. Proc Natl Acad Sci U S A (1988) 2.84

Tissue-specific DNaseI hypersensitive sites in the 5'-flanking sequences of the tryptophan oxygenase and the tyrosine aminotransferase genes. EMBO J (1984) 2.42

Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF. Mol Cell Biol (1997) 2.37

Activity of two different silencer elements of the chicken lysozyme gene can be compensated by enhancer elements. EMBO J (1987) 2.07

Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements. EMBO J (1987) 1.87

Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74

Negative transcriptional regulation mediated by thyroid hormone response element 144 requires binding of the multivalent factor CTCF to a novel target DNA sequence. J Biol Chem (1999) 1.62

Lysozyme gene activity in chicken macrophages is controlled by positive and negative regulatory elements. Nucleic Acids Res (1987) 1.54

Transcriptional regulation of the tryptophan oxygenase gene in rat liver by glucocorticoids. J Biol Chem (1983) 1.48

Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol Cell Biol (1999) 1.42

Ribosomal DNA of fly Sciara coprophila has a very small and homogeneous repeat unit. Mol Gen Genet (1979) 1.39

Expression of a chicken lysozyme recombinant gene is regulated by progesterone and dexamethasone after microinjection into oviduct cells. Cell (1982) 1.37

The glucocorticoid receptor. Biochim Biophys Acta (1991) 1.35

The minimal repression domain of MBD2b overlaps with the methyl-CpG-binding domain and binds directly to Sin3A. J Biol Chem (2000) 1.32

rRNA processing: removal of only nineteen bases at the gap between 28S alpha and 28S beta rRNAs in Sciara coprophila. Nucleic Acids Res (1985) 1.23

DNA bending by the silencer protein NeP1 is modulated by TR and RXR. Nucleic Acids Res (1996) 1.20

NeP1. A ubiquitous transcription factor synergizes with v-ERBA in transcriptional silencing. J Mol Biol (1993) 1.14

Expression of pheromone binding proteins during antennal development in the gypsy moth Lymantria dispar. J Neurosci (1989) 1.13

A new method for constructing linker scanning mutants. Nucleic Acids Res (1987) 1.10

The glucocorticoid receptor is associated with the RNA-binding nuclear matrix protein hnRNP U. J Biol Chem (1997) 1.09

Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem (2000) 1.03

Repetitive sequence involvement in the duplication and divergence of mouse lysozyme genes. EMBO J (1990) 0.98

The DNA-binding and tau2 transactivation domains of the rat glucocorticoid receptor constitute a nuclear matrix-targeting signal. Mol Endocrinol (1998) 0.98

Co-operative binding of the glucocorticoid receptor DNA binding domain is one of at least two mechanisms for synergism. J Mol Biol (1991) 0.94

Effects of the heterogeneous nuclear ribonucleoprotein U (hnRNP U/SAF-A) on glucocorticoid-dependent transcription in vivo. J Steroid Biochem Mol Biol (2001) 0.92

Cooperative interaction of chicken lysozyme enhancer sub-domains partially overlapping with a steroid receptor binding site. Nucleic Acids Res (1989) 0.92

Repression of the mouse M-lysozyme gene involves both hindrance of enhancer factor binding to the methylated enhancer and histone deacetylation. Nucleic Acids Res (1998) 0.91

Multiple domains of the glucocorticoid receptor involved in synergism with the CACCC box factor(s). Mol Endocrinol (1991) 0.91

The insulator protein CTCF represses transcription on binding to the (gt)(22)(ga)(15) microsatellite in intron 2 of the HLA-DRB1(*)0401 gene. Gene (2000) 0.90

Independent replication of the ribosomal RNA genes in the polytrophic-meroistic ovaries of Calliphora erythrocephala, Drosophila hydei, and Sarcophaga barbata. Chromosoma (1975) 0.90

Transient expression of the chicken lysozyme gene after transfer into human cells. EMBO J (1982) 0.90

Identification of nucleolin as a glucocorticoid receptor interacting protein. Biochem Biophys Res Commun (2001) 0.89

Modulation of thyroid hormone receptor silencing function by co-repressors and a synergizing transcription factor. Biochem Soc Trans (2000) 0.89

Factors influencing nuclear receptors in transcriptional repression. Semin Cancer Biol (1994) 0.88

Methylation of the mouse M-lysozyme downstream enhancer inhibits heterotetrameric GABP binding. Nucleic Acids Res (1995) 0.87

The mouse M-lysozyme gene domain: identification of myeloid and differentiation specific DNasel hypersensitive sites and of a 3'-cis acting regulatory element. Nucleic Acids Res (1992) 0.84

At least three subdomains of v-erbA are involved in its silencing function. Mol Endocrinol (1997) 0.84

The involvement of demethylation in the myeloid-specific function of the mouse M lysozyme gene downstream enhancer. Nucleic Acids Res (1992) 0.84

Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. Anticancer Res (2000) 0.83

Multiple receptor interaction domains of GRIP1 function in synergy. Nucleic Acids Res (1998) 0.83

Two silencing sub-domains of v-erbA synergize with each other, but not with RXR. Nucleic Acids Res (1994) 0.81

The thyroid hormone receptor and the insulator protein CTCF: two different factors with overlapping functions. J Steroid Biochem Mol Biol (2002) 0.81

Lysozyme gene expression and regulation. EXS (1996) 0.81

A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J Biol Chem (1995) 0.81

Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR. Mol Endocrinol (1998) 0.80

DNase I hypersensitive sites far upstream of the rat tryptophan oxygenase gene direct developmentally regulated transcription in livers of transgenic mice. Mech Dev (1994) 0.80

Cis-elements required for the demethylation of the mouse M-lysozyme downstream enhancer. J Biol Chem (1997) 0.79

tau4/tau c/AF-2 of the thyroid hormone receptor relieves silencing of the retinoic acid receptor silencer core independent of both tau4 activation function and full dissociation of corepressors. Mol Cell Biol (1997) 0.79

Complex protein binding to the mouse M-lysozyme gene downstream enhancer involves single-stranded DNA binding. Gene (1997) 0.79

EcR interacts with corepressors and harbours an autonomous silencing domain functional in both Drosophila and vertebrate cells. J Steroid Biochem Mol Biol (1999) 0.77

The (gt)n(ga)m containing intron 2 of HLA-DRB alleles binds a zinc-dependent protein and forms non B-DNA structures. Gene (1999) 0.77

Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6. Mol Endocrinol (2000) 0.76

A thyroid hormone receptor-dependent glucocorticoid induction. Mol Endocrinol (1994) 0.76

Expression of the chicken lysozyme gene after transfer into homologous and heterologous cells. Prog Clin Biol Res (1982) 0.75

Distinct proteins interacting with the glucocorticoid receptor. Z Rheumatol (2000) 0.75

A gel retardation assay system for studying protein binding to simple repetitive DNA sequences. Electrophoresis (1992) 0.75

Steroid controlled expression of the chicken lysozyme and the rat tryptophan oxygenase gene after transfer into eukaryotic cells. J Steroid Biochem (1984) 0.75

In vivo protein interaction with the mouse M-lysozyme gene downstream enhancer correlates with demethylation and gene expression. Cell Growth Differ (1996) 0.75